Rapid Detection of Anti-IFN-α2 Autoantibodies Using a New Automated VIDAS Assay Prototype.

1 avril 2025 Publications

Autoantibodies neutralizing Type I interferons increase the risk of severe viral diseases and are linked to autoimmune conditions. The automated VIDAS assay is suitable for anti-IFN-α2 IgGs quantification, offering a swift, reliable, user-friendly, single test for clinical management.

DOI: 10.1002/eji.202451516, PMID: 40223598
Authors: Sylvie Pons, Laurence Generenaz, Adrian Gervais, Anne Puel, Paul Bastard, Nathalie Renard, Valerie Guyot, Cecile Vinit, Fei Zheng, Karen Brengel-Pesce, Kahina Saker, Jean-Christophe Richard, Alexis Mathian, Zahir Amoura, Karim Dorgham, Guy Gorochov, Jean-Laurent Casanova, Aurore Fleurie, Sophie Trouillet-Assant

See the publication on Pubmed

Rapid Detection of Anti-IFN-α2 Autoantibodies Using a New Automated VIDAS Assay Prototype.

Expanding the scope of human immunology in the .

Autoantibodies neutralizing type 1 interferons in two cohorts of people with HIV.

Autoantibodies neutralizing type I IFNs in a fatal case of H5N1 avian influenza.

Autres articles

Expanding the scope of human immunology in the .

Autoantibodies neutralizing type 1 interferons in two cohorts of people with HIV.

Autoantibodies neutralizing type I IFNs in a fatal case of H5N1 avian influenza.